Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer

SIMPLE SUMMARY: Human epidermal growth factor receptor 2 (HER2) amplification has emerged as a biomarker of metastatic colorectal cancer (mCRC). Prospective clinical trials have demonstrated the efficacy of HER2-targeted therapies for HER2-positive mCRC and explored the underlying mechanisms. To imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshikawa, Ayumu, Nakamura, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818808/
https://www.ncbi.nlm.nih.gov/pubmed/36612185
http://dx.doi.org/10.3390/cancers15010183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818808/
https://www.ncbi.nlm.nih.gov/pubmed/36612185
http://dx.doi.org/10.3390/cancers15010183

Ejemplares similares